Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Shashank Jaitly"'
Autor:
Priya Thakur, Nupur Bhargava, Shashank Jaitly, Pragya Gupta, Saurabh Kumar Bhattacharya, G. Padma, Saroja Kondaveeti, Suman Jain, Sivaprakash Ramalingam
Publikováno v:
Stem Cell Research, Vol 50, Iss , Pp 102124- (2021)
β-thalassemia (BT) is a hereditary blood disorder caused by mutations in the β-globin (HBB) gene leading to severely reduced or no synthesis of the β-chain of adult hemoglobin. IVS1-5 (G > C) is the most common BT mutation in Indian population and
Externí odkaz:
https://doaj.org/article/795b1d055132407c8d882c92e1711f0b
Autor:
Nupur Bhargava, Shashank Jaitly, Sangam Giri Goswami, Suman Jain, Debojyoti Chakraborty, Sivaprakash Ramalingam
Publikováno v:
Stem Cell Research, Vol 39, Iss , Pp - (2019)
Sickle cell disease (SCD) is an autosomal recessive disorder caused by a mutation in β-globin (HBB) gene. We have generated an induced pluripotent stem cell (iPSC) line, IGIBi001-A from an Indian sickle cell patient with a homozygous HBB gene mutati
Externí odkaz:
https://doaj.org/article/60760645ae15464896992fabe977f3d8
Autor:
Nupur Bhargava, Priya Thakur, Thulasi Priyadharshini Muruganandam, Shashank Jaitly, Pragya Gupta, Neelam Lohani, Sangam Giri Goswami, Vinodh Saravanakumar, Saurabh Kumar Bhattacharya, Suman Jain, Sivaprakash Ramalingam
Publikováno v:
Molecular Biology Reports. 49:7887-7898
Disease-specific human induced pluripotent stem cells (hiPSCs) can be generated directly from individuals with known disease characteristics or alternatively be modified using genome editing approaches to introduce disease causing genetic mutations t
Autor:
Pragya Gupta, Shashank Jaitly, Priya Thakur, Sangam Giri Goswami, Nupur Bhargava, Sivaprakash Ramalingam
Publikováno v:
Genome Editing in Drug Discovery. :231-259
Autor:
Priya Thakur, Thulasi Priyadharshini Muruganandam, Nupur Bhargava, Neelam Lohani, Pragya Gupta, S. Bhattacharya, Suman L. Jain, Shashank Jaitly, Sivaprakash Ramalingam, Sangam Giri Goswami
Disease-specific human induced pluripotent stem cells (hiPSCs) can be generated directly from individuals with known disease characteristics or alternatively be modified using genome editing approaches to introduce disease causing genetic mutations t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::55101324278bf820bca53f18948c81f8
https://doi.org/10.1101/2021.07.31.453934
https://doi.org/10.1101/2021.07.31.453934
Autor:
Saroja Kondaveeti, Sivaprakash Ramalingam, Pragya Gupta, Suman L. Jain, Nupur Bhargava, G. Padma, Shashank Jaitly, S. Bhattacharya, Priya Thakur
Publikováno v:
Stem Cell Research, Vol 50, Iss, Pp 102124-(2021)
β-thalassemia (BT) is a hereditary blood disorder caused by mutations in the β-globin (HBB) gene leading to severely reduced or no synthesis of the β-chain of adult hemoglobin. IVS1-5 (G > C) is the most common BT mutation in Indian population and
Autor:
Sangam Giri Goswami, Nupur Bhargava, Debojyoti Chakraborty, Shashank Jaitly, Suman Jain, Sivaprakash Ramalingam
Publikováno v:
Stem Cell Research, Vol 39, Iss, Pp-(2019)
Sickle cell disease (SCD) is an autosomal recessive disorder caused by a mutation in β-globin (HBB) gene. We have generated an induced pluripotent stem cell (iPSC) line, IGIBi001-A from an Indian sickle cell patient with a homozygous HBB gene mutati